Evidence map›Paper›PMID 31762620›Full record

ReviewSaudi journal of biological sciences2019

Lifestyle interventions for non-alcoholic fatty liver disease.

Idris Adewale Ahmed, Maryam Abimbola Mikail, Mohammad Rais Mustafa, Muhammad Ibrahim, Rozana Othman

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Saudi journal of biological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. The Antitumor Effects of α-Linolenic Acid.Journal of personalized medicine · 2024
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Customized liver organoids as an advancedInternational journal of biological sciences · 2023
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Idris Adewale AhmedThe Center for Natural Products Research and Drug Discovery (CENAR), Wellness Research Cluster, University of Malaya, 50603 Kuala Lumpur, Malaysia.
Maryam Abimbola MikailDepartment of Biomedical Science, Faculty of Science, Lincoln University College, Malaysia.
Mohammad Rais MustafaThe Center for Natural Products Research and Drug Discovery (CENAR), Wellness Research Cluster, University of Malaya, 50603 Kuala Lumpur, Malaysia.
Muhammad IbrahimInternational Islamic University Malaysia, Kuantan Campus, Malaysia.
Rozana OthmanThe Center for Natural Products Research and Drug Discovery (CENAR), Wellness Research Cluster, University of Malaya, 50603 Kuala Lumpur, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a multi-factorial disease and the most common of chronic liver diseases worldwide. The four clinical-pathological entities which are usually followed by NAFLD course include non-alcoholic steatosis, non-alcoholic steatohepatitis, advanced fibrosis/cirrhosis, and hepatocellular carcinoma. The cornerstones of NAFLD management and treatment, however, are healthy lifestyles such as dietary modifications, regular physical activity, and gradual weight loss. At present, no drugs or pharmacological agents have been approved for long-term treatment of NAFLD. Therefore, lifestyle modification is considered the main clinical recommendation and an initial step for the management of NAFLD.

Indexed as

AASLD, American Association for the Study of Liver DiseasesALA, alpha-linolenic acidDDT, dichlorodiphenyltrichloroethaneDHA, docosahexaenoic acidDietEASD, European Association for the Study of DiabetesEASL, European Association for the Study of the LiverEASO, European Association for the Study of ObesityEPA, eicosapentaenoic acidExerciseLifestyleLiver diseaseNAFLD, non-alcoholic fatty liver diseaseNASH, non-alcoholic steatohepatitisWeight loss

Identifiers

PMID31762620
PMCPMC6864195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.